Home/Filings/4/0001415889-23-015861
4//SEC Filing

Stanton Matthew 4

Accession 0001415889-23-015861

CIK 0001733294other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:30 PM ET

Size

5.4 KB

Accession

0001415889-23-015861

Insider Transaction Report

Form 4
Period: 2023-12-01
Stanton Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2023-12-01+76,31076,310 total
    Exercise: $1.39Exp: 2033-11-30Common Stock (76,310 underlying)
Footnotes (1)
  • [F1]The option to purchase 76,310 shares of common stock was granted on December 1, 2023. The shares underlying the option vest over two years, with 25% of the shares vesting on June 1, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0001814198

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:30 PM ET
Size
5.4 KB